My Application Form Status

Check the status of your application form with Angel Broking.
Idea Cellular hits 52-week low after weak Q1 results
Aug 09,2016

The result was announced after market hours yesterday, 8 August 2016.

Meanwhile, the S&P BSE Sensex was down 5.24 points or 0.02% at 28,177.33.

On BSE, so far 2.96 lakh shares were traded in the counter as against average daily volume of 10.99 lakh shares in the past one quarter. The stock hit a low of Rs 96.55 so far during the day, which is a 52-week low for the counter. The stock hit a high of Rs 99.50 so far during the day. The stock had hit a 52-week high of Rs 170.75 on 7 August 2015. The stock had underperformed the market over the past one month till 8 August 2016, advancing 1.18% compared with 3.89% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 9.2% as against Sensexs 11.71% rise.

The large-cap company has equity capital of Rs 3600.92 crore. Face value per share is Rs 10.

Idea Cellular said it remains confident to tap all emerging opportunities in mobile voice and broadband business.

Idea Cellular is one of the leading telecom operators in India. It is a part of the Aditya Birla Group.

Powered by Capital Market - Live News

Colgate-Palmolive (India) hits 52-week high after announcing Q1 results
Aug 08,2016

The result was announced during market hours today, 8 August 2016.

Meanwhile, the S&P BSE Sensex was up 99.02 points or 0.35% at 28,177.37.

The stock surged on heavy volumes. On BSE, so far 3 lakh shares were traded in the counter as against average daily volume of 36,004 shares in the past one quarter. The stock hit a high of Rs 1,032.85 so far during the day, which is a 52-week high for the counter. The stock hit a low of Rs 940 so far during the day. The stock had hit a 52-week low of Rs 787.60 on 24 May 2016. The stock had underperformed the market over the past one month till 5 August 2016, advancing 2.01% compared with 3.36% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 13.19% as against Sensexs 11.15% rise.

The large-cap company has equity capital of Rs 27.20 crore. Face value per share is Rs 1.

Colgate-Palmolive (India) achieved a volume growth of 6% in Q1 June 2016 over Q1 June 2015.

Colgate-Palmolive (India) makes oral care products.

Powered by Capital Market - Live News

Kovai Medical Center hits the roof after strong Q1 results
Aug 08,2016

The result was announced after trading hours on Friday, 5 August 2016.

Meanwhile, the BSE Sensex was up 83.86 points, or 0.30%, to 28,162.21.

On BSE, so far 3,116 shares were traded in the counter, compared with average daily volume of 1,158 shares in the past one quarter. The stock opened with an upward gap of 5% at Rs 762.75 and remained stuck at that level so far. The stock hit a record high of Rs 928.25 on 11 August 2015. The stock hit a 52-week low of Rs 616.25 on 18 February 2016. The stock had outperformed the market over the past 30 days till 5 August 2016, rising 3.85% compared with 3.22% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 2.39% as against Sensexs 11.30% rise.

The small-cap company has an equity capital of Rs 10.94 crore. Face value per share is Rs 10.

Kovai Medical Center & Hospital is a multispecialty hospital in Coimbatore.

Powered by Capital Market - Live News

Wockhardt slumps as USFDA issues import alert on the companys Ankleshwar unit
Aug 08,2016

The company made the announcement during market hours today, 8 August 2016.

Meanwhile, the S&P BSE Sensex was up 77.95 points or 0.28% at 28,156.30.

On BSE, so far 5.78 lakh shares were traded in the counter as against average daily volume of 1.79 lakh shares in the past one quarter. The stock hit a high of Rs 960 and a low of Rs 870 so far during the day. The stock had hit a 52-week high of Rs 1,748.20 on 2 December 2015. The stock had hit a 52-week low of Rs 706.35 on 12 February 2016. The stock had outperformed the market over the past one month till 5 August 2016, advancing 6.19% compared with 3.36% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, gaining 4.51% as against Sensexs 11.15% rise.

The large-cap company has equity capital of Rs 55.27 crore. Face value per share is Rs 5.

The company has already initiated required steps to address the concerns raised by the US Food and Drug Administration (USFDA) and is putting all efforts to resolve the matter, Wockhardt said in a statement.

Meanwhile, media reports suggested that a foreign brokerage has downgraded the stock to neutral from outperform in the wake of USFDAs import alert on the companys Ankleshwar unit.

Wockhardt is scheduled to announce Q1 June 2016 results on 13 August 2016. The companys consolidated net profit rose 25.9% to Rs 42.90 crore on 6.1% decline in net sales to Rs 1013.36 crore in Q4 March 2016 over Q4 March 2015.

Wockhardt is a research based and technology intensive global pharmaceutical and biotechnology company.

Powered by Capital Market - Live News

Hero MotoCorp gains after reporting record quarterly net profit in Q1
Aug 08,2016

The announcement was made during trading hours today, 8 August 2016.

Meanwhile, the BSE Sensex was up 97.30 points, or 0.35%, to 28,175.65.

On BSE, so far 1.13 lakh shares were traded in the counter, compared with average daily volume of 25,020 shares in the past one quarter. The stock hit a high of Rs 3,553.55 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 3,410 so far during the day. The stock hit a 52-week low of Rs 2,259.10 on 7 September 2015. The stock had outperformed the market over the past 30 days till 5 August 2016, rising 10.74% compared with 3.22% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 19.04% as against Sensexs 11.30% rise.

The large-cap company has an equity capital of Rs 39.94 crore. Face value per share is Rs 2.

Hero MotoCorps net profit rose 18.13% to Rs 883.10 crore on 7.84% increase in total income to Rs 8131.04 crore in Q1 June 2016 over Q1 June 2015. The company said its gross turnover (gross sales and other operating income) rose 7.74% to Rs 8010.66 crore in Q1 June 2016 over Q1 June 2015. Earnings before interest, depreciation, tax & amortization (EBIDTA) margin was reported at 16.63% in Q1 June 2016, higher than 15.09% in Q1 June 2015.

The companys chairman, managing director and chief executive officer, Pawan Munjal, said that the first quarter of this fiscal carried forward the growth trajectory that the company had set in the previous quarter. The sales growth is reflected in the positive financial results for the quarter, and has given the company the momentum to carry forward as it prepares for the upcoming festive season. With the above-average monsoon so far and the implementation of the 7th Pay Commission recommendations, the firm remains cautiously optimistic about the remaining months of the financial year ending March 2017.

Hero MotoCorp said it sold 17.45 lakh units of two-wheelers in Q1 June 2016, up 6.08% against 16.45 lakh units in Q1 June 2015. This is the highest-ever quarterly sales for Hero MotoCorp.

Providing additional momentum to the growth trajectory has been the 125cc segment where the company now commands well over 50% market share, thanks to the large volume contributions from Glamour and Super Splendor. In Q1 June 2016, Glamour grew by 32% and Super Splendor grew by 29% over Q1 June 2015.

Hero MotoCorp recently launched the all-new Splendor iSmart 1 10 n++ the first motorcycle to have been completely designed and developed by the in-house R&D team at the Hero Centre of Innovation and Technology (CIT) at Jaipur, and the initial response from customers have been positive.

Hero MotoCorp is the worlds largest two-wheeler manufacturer in terms of production capacity.

Powered by Capital Market - Live News

Vesuvius India hits record high after robust Q2 outcome
Aug 08,2016

The result was announced during market hours today, 8 August 2016.

Meanwhile, the S&P BSE Sensex was up 72.64 points or 0.26% at 28,150.99.

On BSE, so far 25,000 shares were traded in the counter as against average daily volume of 750 shares in the past one quarter. The stock hit a high of Rs 1,033 so far during the day, which is a record high for the counter. The stock hit a low of Rs 904.95 so far during the day. The stock had hit a 52-week low of Rs 620 on 25 August 2015. The stock had underperformed the market over the past one month till 5 August 2016, advancing 0.76% compared with 3.36% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 12.17% as against Sensexs 11.15% rise.

The small-cap company has equity capital of Rs 20.30 crore. Face value per share is Rs 10.

Vesuvius India is primarily a manufacturer and trader of refractories.

Powered by Capital Market - Live News

Muthoot Finance spurts after clarification
Aug 08,2016

The company issued the clarification on Sunday, 7 August 2016.

Meanwhile, the BSE Sensex was up 110.97 points, or 0.40%, to 28,189.32.

On BSE, so far 2.68 lakh shares were traded in the counter, compared with average daily volume of 1.17 lakh shares in the past one quarter. Trading was volatile on the counter. The stock rose 7.73% at the days high of Rs 378.85 so far during the day. The stock fell 2.18% at the days low of Rs 344 in early trade. The stock hit a 52-week high of Rs 395.80 on 1 August 2016. The stock hit a 52-week low of Rs 152 on 23 September 2015. The stock had outperformed the market over the past 30 days till 5 August 2016, rising 26.52% compared with 3.22% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 82.58% as against Sensexs 11.30% rise.

The large-cap company has an equity capital of Rs 399.05 crore. Face value per share is Rs 10.

The officials of income tax department carried out a search at various premises of the company which commenced at 9:00 am on 5 August 2016 and continued till 7:00 am on 7 August 2016. The company said it cooperated with the investigation and has provided information and clarification sought by the officials. The firm said it is confident that the income tax department would have found during the search proceedings that books of accounts of the company have been maintained satisfactorily. The company clarified that it is not expecting any material adverse findings against the company by income tax department.

In a separate announcement on Saturday, 6 August 2016, Muthoot Finance said that it is the highest tax payer in Kerala. It paid Rs 524 crore during 2015-2016 as per audited financial statements for the year ended 31 March 2016.

Muthoot Finances net profit rose 47.56% to Rs 270.27 crore on 13.85% increase in total income to Rs 1300.82 crore in Q1 June 2016 over Q1 June 2015.

Muthoot Finance is the largest gold financing company in India in terms of loan portfolio.

Powered by Capital Market - Live News

Hero MotoCorp gains after decent Q1 results
Aug 08,2016

The announcement was made during trading hours today, 8 August 2016.

Meanwhile, the BSE Sensex was up 78.70 points, or 0.28%, to 28,157.05.

On BSE, so far 56,000 shares were traded in the counter, compared with average daily volume of 25,020 shares in the past one quarter. The stock hit a high of Rs 3,525 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 3,410 so far during the day. The stock hit a 52-week low of Rs 2,259.10 on 7 September 2015. The stock had outperformed the market over the past 30 days till 5 August 2016, rising 10.74% compared with 3.22% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 19.04% as against Sensexs 11.30% rise.

The large-cap company has an equity capital of Rs 39.94 crore. Face value per share is Rs 2.

Hero MotoCorp is the worlds largest two-wheeler manufacturer in terms of production capacity.

Powered by Capital Market - Live News

Aurobindo Pharma inches up after USFDA nod for a drug
Aug 08,2016

The announcement was made during market hours today, 8 August 2016.

Meanwhile, the S&P BSE Sensex was up 82.63 points or 0.29% at 28,160.98.

On BSE, so far 1.14 lakh shares were traded in the counter as against average daily volume of 1.24 lakh shares in the past one quarter. The stock hit a high of Rs 781.90 and a low of Rs 768 so far during the day. The stock had hit a record high of Rs 891.50 on 30 December 2015. The stock had hit a 52-week low of Rs 582 on 25 February 2016. The stock had underperformed the market over the past one month till 5 August 2016, advancing 0.12% compared with 3.36% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 4.36% as against Sensexs 11.15% rise.

The large-cap company has equity capital of Rs 58.52 crore. Face value per share is Rs 1.

Aurobindo Pharma expects to launch the product in the current quarter (Q2 September 2016). The approved abbreviated new drug application (ANDA) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Zyvox Injection, 600 mg/300 mL (2 mg/mL), of Pharmacia & Upjohn Company (Pharmacia). Linezolid Injection is an anti-infective used to treat infections caused by susceptible Gram-positivebacteria in some specific conditions. The approved product has an estimated market size of $87 million in the US for the twelve months ended June 2016 according to IMS.

On consolidated basis, Aurobindo Pharmas net profit rose 39.4% to Rs 562.85 crore on 16.9% growth in net sales to Rs 3674.70 crore in Q4 March 2016 over Q4 March 2015.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The companys manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, Japan PMDA, WHO, Health Canada, MCC South Africa, ANVISA Brazil. The companys robust product portfolio is spread over 7 major therapeutic/product areas encompassing antibiotics, anti-retrovirals, CVS, CNS, gastroenterologicals, anti-allergies and anti-diabetics, supported by an outstanding R&D set-up. The company is marketing these products globally, in over 150 countries.

Powered by Capital Market - Live News

Volumes jump at Bombay Burmah Trading Corporation counter
Aug 08,2016

Bombay Burmah Trading Corporation clocked volume of 2.11 lakh shares by 12:36 IST on BSE, a 29.76-times surge over two-week average daily volume of 7,000 shares. The stock rose 15.72% to Rs 468.60.

NTPC notched up volume of 50.74 lakh shares, a 17.91-fold surge over two-week average daily volume of 2.83 lakh shares. The stock fell 0.81% to Rs 160.

Indian Bank saw volume of 44.41 lakh shares, a 10.42-fold surge over two-week average daily volume of 4.26 lakh shares. The stock fell 0.67% to Rs 199.40.

Britannia Industries clocked volume of 1.12 lakh shares, a 9.68-fold surge over two-week average daily volume of 12,000 shares. The stock rose 7.81% to Rs 3,106.60 after consolidated net profit rose 13.15% to Rs 219.13 on 9.73% increase in total income to Rs 2236.05 crore in Q1 June 2016 over Q1 June 2015. The result was announced during trading hours today, 8 August 2016.

Zensar Technologies saw volume of 2.02 lakh shares, a 8.45-fold rise over two-week average daily volume of 24,000 shares. The stock rose 0.21% to Rs 1,106.

Powered by Capital Market - Live News

HDFC, Max Financial Services nudge higher
Aug 08,2016

HDFC (up 1.05% at Rs 1,354.50) and Max Financial Services (up 0.91% at Rs 556) edged higher.

Meanwhile, the S&P BSE Sensex was up 83.66 points or 0.3% at 28,162.01.

Max Financial Services (MFSL) in its board meeting scheduled today, 8 August 2016, for the purpose of announcing Q1 June 2016 results, will also consider the proposed scheme of arrangement amongst the company, Max Life Insurance Company (MLIC) and HDFC Life Insurance Company (HDFC Life) and consequently, including Max India (formerly Taurus Ventures) as a party to such scheme for certain commercial reasons.

It may be recalled that MFSLs board in its meeting held on 17 June 2016, approved entering into a confidentiality, exclusivity and standstill agreement to evaluate a potential combination through a merger of MLIC and MFSL into HDFC Life by way of a scheme of arrangement.

HDFC Life is a partnership between HDFC, Indias leading housing finance institution and Standard Life, a global long term investment savings player. Currently HDFC holds 62% and Standard Life (Mauritius Holdings) 2006 holds 35% of equity in HDFC Life, while the rest is held by others.

MLIC is a joint venture between MFSL and Mitsui Sumitomo Insurance (MSI), a Japan headquartered global leader in insurance. MFSL holds 68% equity in MLIC, while MSI holds 26%.

Powered by Capital Market - Live News

Britannia Industries spurts after good Q1 earnings
Aug 08,2016

The result was announced during trading hours today, 8 August 2016.

Meanwhile, the BSE Sensex was up 59.97 points, or 0.21%, to 28,138.32.

On BSE, so far 93,000 shares were traded in the counter, compared with average daily volume of 21,293 shares in the past one quarter. The stock hit a high of Rs 3,103.80 and a low of Rs 2,885.10 so far during the day. The stock hit a record high of Rs 3,435 on 13 August 2015. The stock hit a 52-week low of Rs 2,506.65 on 12 February 2016. The stock had underperformed the market over the past 30 days till 5 August 2016, rising 2.48% compared with 3.22% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 2.39% as against Sensexs 11.30% rise.

The large-cap company has an equity capital of Rs 24 crore. Face value per share is Rs 2.

Britannia Industries said in a press release that consolidated profit from operations rose 11% to Rs 288 crore and net profit rose 13% to Rs 219 crore in Q1 June 2016 over Q1 June 2015. Consolidated revenue grew 8% for at Rs 2162 crore in Q1 June 2016 over Q1 June 2015.

Commenting on the performance, Varun Berry, managing director, said that the category growths remained subdued during the quarter, however a good monsoon and impact of 7th pay commission would aid consumption and boost demand going forward. The deteriorating geopolitical situation and currency fluctuations in certain geographies like Middle East and Africa have also impacted the companys growths. The firm launched some delightful products like Good day Nuts cookies, NutriChoice Oat cookies & Biscotti during the quarter which bolstered growth. The company intends to drive consumer off take & strengthen its momentum through re-stage of its brands and plugging its product portfolio gaps going forward. Commodity prices have firmed up significantly over the last two quarters and the firm has initiated a combination of price increase & cost efficiency measures to address this. With a strengthened back end in terms of technologically superior factories and state-of-the-art R&D centre, the company is confident of delivering new products for consumers, he added.

Britannia Industries makes biscuits, bread, rusk, cakes and dairy products like cheese, butter and milk.

Powered by Capital Market - Live News

Hindalco hits 52-week high after strong Q1 earnings from Novelis
Aug 08,2016

Meanwhile, the S&P BSE Sensex was up 99.70 points or 0.36% at 28,178.05.

On BSE, so far 10.92 lakh shares were traded in the counter as against average daily volume of 14.12 lakh shares in the past one quarter. The stock hit a high of Rs 151.90 so far during the day, which is a 52-week high for the counter. The stock hit a low of Rs 145.70 so far during the day. The stock had hit a 52-week low of Rs 58.85 on 12 February 2016. The stock had outperformed the market over the past one month till 5 August 2016, advancing 16.34% compared with 3.36% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 58.9% as against Sensexs 11.15% rise.

The large-cap company has equity capital of Rs 206.50 crore. Face value per share is Rs 1.

Novelis adjusted net profit rose 37.5% to $33 million in Q1 June 2016 over Q1 June 2015. Net sales declined 13% to $2.3 billion in Q1 June 2016 over Q1 June 2015, due to lower average aluminum prices and local market premiums, as well as lower total shipments, which was partially offset by increased shipments of higher conversion premium products.

Novelis adjusted earnings before interest, taxation, depreciation and amortization (EBITDA) rose 26% to $268 million in Q1 June 2016 over Q1 June 2015, driven by higher productivity and lower costs associated with the start-up of new automotive finishing and recycling capacity in the prior year.

Hindalco is scheduled to announce Q1 June 2016 results on Friday, 12 August 2016. Net profit jumped 123.4% to Rs 356.33 crore on 7.3% decline in net sales to Rs 8542.66 crore in Q4 March 2016 over Q4 March 2015.

A part of the Aditya Birla Group, Hindalco Industries is the worlds largest aluminium rolling company and one of the biggest producers of primary aluminium in Asia. Its copper smelter is amongst the largest single location custom smelter globally.

Powered by Capital Market - Live News

Wockhardt slumps on reports of brokerage downgrade
Aug 08,2016

Meanwhile, the BSE Sensex was up 94.99 points, or 0.34%, to 28,173.34.

On BSE, so far 4.47 lakh shares were traded in the counter, compared with average daily volume of 1.79 lakh shares in the past one quarter. The stock hit a high of Rs 960 and a low of Rs 870 so far during the day. The stock hit a 52-week high of Rs 1,748.20 on 2 December 2015. The stock hit a 52-week low of Rs 706.35 on 12 February 2016. The stock had outperformed the market over the past 30 days till 5 August 2016, rising 8.13% compared with 3.22% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 8.43% as against Sensexs 11.30% rise.

The large-cap company has an equity capital of Rs 55.27 crore. Face value per share is Rs 5.

The downgrade was followed by media reports suggesting that Wockhardts Ankleshwar plant received an import alert from the US Food and Drugs Administration (USFDA) for alleged violation of good manufacturing practices.

According to reports, the foreign brokerage said that the Ankleshwar facility receiving under import alert may lead to Wockhardts multiples falling under pressure in the near term. However, the brokerage reportedly remains bullish on the stock for long term.

Reports sugested that the USFDA had carried out an inspection at the Ankleshwar plant in November last year and issued adverse observations known as Form 483 for violating good manufacturing practices. The Ankleshwar plant makes both formulations and active pharmaceutical ingredients and largely caters to domestic and European markets. However, it exports some formulations and active pharmaceutical ingredients (APIs) to Wockhardts US plant.

On a consolidated basis, net profit of Wockhardt rose 25.88% to Rs 42.90 crore on 6.10% decline in net sales to Rs 1013.36 crore in Q4 March 2016 over Q4 March 2015. The company will announce Q1 results on 13 August 2016.

Wockhardt is a research based and technology intensive global pharmaceutical and biotechnology company.

Powered by Capital Market - Live News

Union Bank of India tumbles after weak Q1 numbers
Aug 08,2016

The result was announced on Saturday, 6 August 2016.

Meanwhile, the S&P BSE Sensex was up 92.17 points or 0.33% at 28,170.52.

On BSE, so far 10.17 lakh shares were traded in the counter as against average daily volume of 6.88 lakh shares in the past one quarter. The stock hit a high of Rs 133.65 and a low of Rs 127.20 so far during the day. The stock had hit a 52-week low of Rs 104.05 on 29 February 2016. The stock had hit a 52-week high of Rs 222.45 on 18 August 2015. The stock had underperformed the market over the past one month till 5 August 2016, advancing 1.89% compared with 3.36% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 17.42% as against Sensexs 11.15% rise.

The mid-cap bank has equity capital of Rs 687.44 crore. Face value per share is Rs 10.

Union Bank of Indias domestic net interest margin (NIM) stood at 2.36% in Q1 June 2016 compared with 2.46% in Q1 June 2015. Global NIM stood at 2.28% in Q1 June 2016 as against 2.39% in Q1 June 2015.

The banks average current and savings account (CASA) ratio improved to 29.5% in Q1 June 2016 from 27% in Q1 June 2015 and 29.2% in Q4 March 2016.

Union Bank of Indias gross non-performing assets (NPA) stood at Rs 27280.90 crore as on 30 June 2016 compared with Rs 24170.89 crore as on 31 March 2016 and Rs 14143.62 crore as on 30 June 2015. The ratio of gross NPA to gross advances stood at 10.16% as on 30 June 2016 as against 8.7% as on 31 March 2016 and 5.53% as on 30 June 2015. The ratio of net NPA to net advances stood at 6.16% as on 30 June 2016 compared with 5.25% as on 31 March 2016 and 3.08% as on 30 June 2015.

The banks provisions and contingencies jumped 110.6% to Rs 1352.96 crore in Q1 June 2016 over Q1 June 2015.

Provision coverage ratio stood at 50% as on 30 June 2016 as against 51% as on 31 March 2016 and 58% as on 30 June 2015.

Union Bank of India is one of largest state-owned banks in India. The Government of India (GoI) held 63.44% in Union Bank of India (as per the shareholding pattern as on 30 June 2016).

Powered by Capital Market - Live News